Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe only visible change is the page revision label updated from Revision: v3.4.1 to Revision: v3.4.2, with no observed changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedPublications section updated: added a new long-term efficacy and biomarker exploration paper (J Hepatol. 2026) and revised the citation to v3.4.1; removed the 2025 online-ahead-of-print reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedOnly the revision labels changed: Revision: v3.3.4 was added and Revision: v3.3.3 was removed. No study content, eligibility criteria, or results information was modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a new publication citation for long-term efficacy and biomarker exploration (J Hepatol, 2025, online ahead of print) and updated the revision to v3.3.3. The older citation (v3.3.2) was removed.SummaryDifference0.2%

- Check91 days agoChange DetectedUpdated PubMed-related text to state that publications are auto-filled from PubMed and may not be about the study, and revised the version from v3.2.0 to v3.3.2; the older PubMed-generated wording was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page removed a government funding/operating-status notice, and this change does not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.